BIOXCEL THERAPEUTICS INC. overview
BIOXCEL THERAPEUTICS INC.
> News
GlobeNewsWire published a news.
BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Selected for Presentation at 2024 ASCO Annual Meeting
•
•
GlobeNewsWire •
Stocks •
More BIOXCEL THERAPEUTICS INC. news...
Thank you
Chart
Statistics
- Analyses : 0
- Followers : 0